Related Experiment Video
Updated: Sep 12, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Neurotoxicological concerns: Azole fungicides as mixed/noncompetitive inhibitors of human and rat 5α-reductase 1
Jiachen Lin1, Yinghao Huang2, Yilin Xu2
1Key Laboratory of Precision Anesthesiology of Zhejiang Province, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Key Laboratory of Pediatric Anesthesiology, Ministry of Education, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Department of Anesthesiology and Perioperative Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Department of Ultrasound Medicine, National Key Clinical Specialty (Wound Healing), Wenzhou Key Laboratory of Interventional Ultrasound for Intelligent Healthcare and Clinical Translation, the First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou 325000, China.
Abstract:
Azole fungicides are utilized in global agriculture to protect rice, vegetables, and fruits from fungal pathogens, yet their capacity to interfere with neurosteroid biosynthesis has raised significant toxicological concerns. In this study, we investigated the effects of eleven representative azole fungicides on the enzymatic activity of 5α-reductase 1 (SRD5A1) using both human and rat models. To assess inhibition, we employed HPLC-MS/MS to precisely measure testosterone to dihydrotestosterone conversion, complemented by SPR, intact cell assays, in silico docking, molecular dynamics, and 3D-QSAR modeling. Our screening revealed that three azoles inhibited the human isoform, whereas four inhibited the rat counterpart, with ipconazole demonstrating the strongest potency (IC₅₀ = 3.40 μM for human, 15.24 μM for rat). SPR confirmed its tight binding (KD = 2.12 μM) and NADPH disruption. Kinetic analyses classified these as mixed/noncompetitive inhibitors. In SF126 cells, 10 and 100 μM exposures markedly reduced DHT output. SAR correlated efficacy with LogP, and 3D-QSAR highlighted hydrophobic interactions as critical. Docking revealed that azoles occupy the NADPH-binding site via van der Waals forces, hydrogen bonds, hydrophobic contacts, and charge interactions. Collectively, our findings demonstrate that azole fungicides inhibit SRD5A1 across species, potentially causing neural disorders by depleting neurosteroids, underscoring the need for further neurotoxicological research.
Related Concept Videos
Antifungal Agents
Drugs Affecting Neurotransmitter Synthesis
Antiprotozoal Agents
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Anthelminthic Agents

